LBA5 A phase III trial with a 2x2 factorial design in men with de novo metastatic castration-sensitive prostate cancer: Overall survival with abiraterone acetate plus prednisone in PEACE-1
Karim Fizazi, J. Carles Galceran, S. Foulon, Guilhem Roubaud, Ray McDermott, Aude Fléchon, Bertrand Tombal, S. Supiot, Dominik Berthold, Philippe Ronchin, Gabriel Kacsó, G. Gravis Mescam, Fabio Calabrò, Jean François Berdah, Ali Hasbini, M. Silva, Antoine Thiery-Vuillemin, I. Latorzeff, Isabelle Rieger, Alberto Bossi
Topics & Concepts
Abiraterone acetateMedicinePrednisoneProstate cancerOncologyInternal medicineCastrationProstateTestosterone (patch)CancerAbirateroneUrologyHormoneAndrogen deprivation therapyAndrogen receptorProstate Cancer Treatment and ResearchRadiopharmaceutical Chemistry and ApplicationsProstate Cancer Diagnosis and Treatment